Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography, Three-Dimensional | 53 | 2024 | 516 | 10.970 |
Why?
|
Echocardiography | 61 | 2024 | 938 | 8.040 |
Why?
|
Heart Ventricles | 51 | 2024 | 779 | 7.460 |
Why?
|
Tricuspid Valve Insufficiency | 18 | 2024 | 113 | 5.650 |
Why?
|
Ventricular Function, Right | 23 | 2024 | 146 | 4.450 |
Why?
|
Ventricular Function, Left | 33 | 2024 | 605 | 4.330 |
Why?
|
Tricuspid Valve | 15 | 2023 | 97 | 3.480 |
Why?
|
Ventricular Dysfunction, Right | 10 | 2024 | 136 | 2.630 |
Why?
|
Amyloidosis | 13 | 2024 | 127 | 2.410 |
Why?
|
Heart Atria | 13 | 2022 | 282 | 2.290 |
Why?
|
Cardiomyopathies | 8 | 2024 | 264 | 2.260 |
Why?
|
Ventricular Dysfunction, Left | 12 | 2024 | 329 | 2.230 |
Why?
|
Stroke Volume | 26 | 2024 | 463 | 2.200 |
Why?
|
Ventricular Remodeling | 8 | 2024 | 106 | 1.960 |
Why?
|
Heart Failure | 11 | 2023 | 1185 | 1.920 |
Why?
|
Atrial Function, Left | 8 | 2021 | 50 | 1.910 |
Why?
|
Defibrillators, Implantable | 7 | 2024 | 144 | 1.820 |
Why?
|
Mitral Valve Insufficiency | 6 | 2024 | 192 | 1.730 |
Why?
|
Echocardiography, Transesophageal | 12 | 2022 | 346 | 1.670 |
Why?
|
Hypertension, Pulmonary | 6 | 2018 | 353 | 1.660 |
Why?
|
Predictive Value of Tests | 30 | 2024 | 1723 | 1.620 |
Why?
|
Immunoglobulin Light-chain Amyloidosis | 4 | 2024 | 22 | 1.580 |
Why?
|
Reproducibility of Results | 37 | 2024 | 2758 | 1.470 |
Why?
|
Humans | 138 | 2024 | 89357 | 1.440 |
Why?
|
Image Interpretation, Computer-Assisted | 15 | 2024 | 688 | 1.390 |
Why?
|
Reference Values | 19 | 2024 | 661 | 1.350 |
Why?
|
Cardiac Volume | 4 | 2017 | 53 | 1.340 |
Why?
|
Male | 91 | 2024 | 42411 | 1.290 |
Why?
|
Middle Aged | 67 | 2024 | 25974 | 1.280 |
Why?
|
Magnetic Resonance Imaging, Cine | 11 | 2023 | 161 | 1.280 |
Why?
|
Hemodynamics | 6 | 2019 | 731 | 1.270 |
Why?
|
Female | 91 | 2024 | 46202 | 1.210 |
Why?
|
Echocardiography, Doppler | 9 | 2020 | 186 | 1.200 |
Why?
|
Pacemaker, Artificial | 5 | 2024 | 95 | 1.160 |
Why?
|
Atrial Fibrillation | 3 | 2022 | 358 | 1.110 |
Why?
|
Diastole | 10 | 2021 | 141 | 1.080 |
Why?
|
Aged | 50 | 2024 | 19165 | 1.070 |
Why?
|
Heart Diseases | 8 | 2021 | 298 | 1.070 |
Why?
|
Heart-Assist Devices | 6 | 2021 | 757 | 1.060 |
Why?
|
Pulmonary Embolism | 3 | 2023 | 228 | 0.950 |
Why?
|
Thrombophilia | 1 | 2023 | 23 | 0.900 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2023 | 10 | 0.880 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 1242 | 0.850 |
Why?
|
Echocardiography, Doppler, Color | 7 | 2022 | 103 | 0.850 |
Why?
|
Atrial Remodeling | 2 | 2022 | 24 | 0.830 |
Why?
|
Healthy Volunteers | 8 | 2022 | 146 | 0.830 |
Why?
|
Myocardial Contraction | 3 | 2018 | 252 | 0.830 |
Why?
|
Heart | 7 | 2023 | 574 | 0.810 |
Why?
|
Adult | 43 | 2024 | 26607 | 0.790 |
Why?
|
Atrial Function, Right | 4 | 2020 | 13 | 0.770 |
Why?
|
Cardiac Imaging Techniques | 3 | 2020 | 25 | 0.760 |
Why?
|
Cardiac Surgical Procedures | 3 | 2020 | 475 | 0.740 |
Why?
|
Thrombosis | 1 | 2023 | 302 | 0.730 |
Why?
|
Heart Defects, Congenital | 2 | 2014 | 363 | 0.720 |
Why?
|
Aorta, Thoracic | 2 | 2019 | 167 | 0.720 |
Why?
|
Observer Variation | 9 | 2024 | 610 | 0.700 |
Why?
|
Aortic Valve | 5 | 2023 | 244 | 0.650 |
Why?
|
Aortic Valve Stenosis | 5 | 2023 | 143 | 0.650 |
Why?
|
Contrast Media | 5 | 2023 | 1091 | 0.620 |
Why?
|
Guidelines as Topic | 1 | 2019 | 160 | 0.620 |
Why?
|
Trastuzumab | 2 | 2016 | 74 | 0.620 |
Why?
|
Hemothorax | 1 | 2018 | 15 | 0.620 |
Why?
|
Heart Massage | 1 | 2018 | 12 | 0.620 |
Why?
|
Vascular Calcification | 1 | 2019 | 51 | 0.610 |
Why?
|
Aortic Diseases | 1 | 2019 | 102 | 0.610 |
Why?
|
Mitral Valve | 7 | 2022 | 262 | 0.600 |
Why?
|
Ventricular Fibrillation | 1 | 2018 | 68 | 0.600 |
Why?
|
Retrospective Studies | 25 | 2024 | 9057 | 0.590 |
Why?
|
Early Diagnosis | 1 | 2018 | 125 | 0.590 |
Why?
|
Severity of Illness Index | 14 | 2024 | 1840 | 0.570 |
Why?
|
Aged, 80 and over | 18 | 2024 | 6811 | 0.570 |
Why?
|
Prospective Studies | 20 | 2021 | 4289 | 0.550 |
Why?
|
Holography | 1 | 2016 | 5 | 0.550 |
Why?
|
Atherosclerosis | 2 | 2024 | 257 | 0.550 |
Why?
|
Prognosis | 14 | 2024 | 3783 | 0.550 |
Why?
|
Sensitivity and Specificity | 12 | 2017 | 2015 | 0.520 |
Why?
|
Anticoagulants | 2 | 2018 | 427 | 0.500 |
Why?
|
Anthracyclines | 1 | 2015 | 38 | 0.500 |
Why?
|
Pulmonary Valve | 1 | 2015 | 34 | 0.490 |
Why?
|
Taxoids | 1 | 2015 | 130 | 0.480 |
Why?
|
Sex Factors | 5 | 2018 | 1066 | 0.480 |
Why?
|
Heart Arrest | 1 | 2018 | 279 | 0.480 |
Why?
|
Echocardiography, Doppler, Pulsed | 3 | 2019 | 23 | 0.470 |
Why?
|
Electrodes, Implanted | 2 | 2014 | 177 | 0.470 |
Why?
|
Veins | 1 | 2014 | 95 | 0.460 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2013 | 22 | 0.460 |
Why?
|
Organometallic Compounds | 1 | 2014 | 134 | 0.450 |
Why?
|
Mitral Valve Prolapse | 1 | 2013 | 24 | 0.450 |
Why?
|
Algorithms | 5 | 2017 | 1877 | 0.440 |
Why?
|
Cardiac Catheterization | 4 | 2019 | 303 | 0.440 |
Why?
|
Sample Size | 1 | 2013 | 128 | 0.440 |
Why?
|
Machine Learning | 3 | 2020 | 258 | 0.430 |
Why?
|
Decision Making | 1 | 2018 | 667 | 0.430 |
Why?
|
Image Enhancement | 8 | 2019 | 567 | 0.430 |
Why?
|
Ventricular Pressure | 3 | 2018 | 38 | 0.410 |
Why?
|
Quality Improvement | 1 | 2016 | 451 | 0.400 |
Why?
|
Terminology as Topic | 1 | 2013 | 221 | 0.400 |
Why?
|
Health Care Costs | 1 | 2013 | 235 | 0.390 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 249 | 0.390 |
Why?
|
Magnetic Resonance Imaging | 7 | 2023 | 3448 | 0.390 |
Why?
|
Age Factors | 5 | 2024 | 1870 | 0.370 |
Why?
|
Sarcoidosis | 3 | 2016 | 72 | 0.370 |
Why?
|
Transillumination | 2 | 2021 | 9 | 0.360 |
Why?
|
Models, Statistical | 1 | 2013 | 576 | 0.350 |
Why?
|
Takotsubo Cardiomyopathy | 2 | 2022 | 11 | 0.340 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 479 | 0.340 |
Why?
|
Systole | 3 | 2018 | 115 | 0.330 |
Why?
|
Atrial Appendage | 2 | 2021 | 33 | 0.320 |
Why?
|
Myocardium | 2 | 2024 | 571 | 0.320 |
Why?
|
Heart Valve Diseases | 2 | 2024 | 115 | 0.310 |
Why?
|
Risk Factors | 6 | 2024 | 5499 | 0.310 |
Why?
|
Linear Models | 3 | 2018 | 421 | 0.300 |
Why?
|
Multivariate Analysis | 4 | 2018 | 988 | 0.300 |
Why?
|
Immunoglobulin Light Chains | 2 | 2024 | 89 | 0.290 |
Why?
|
Young Adult | 11 | 2022 | 6312 | 0.280 |
Why?
|
Prosthesis Design | 2 | 2019 | 298 | 0.280 |
Why?
|
Elasticity Imaging Techniques | 2 | 2016 | 56 | 0.260 |
Why?
|
Survival Rate | 4 | 2024 | 1901 | 0.260 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 1597 | 0.260 |
Why?
|
Pandemics | 2 | 2021 | 773 | 0.250 |
Why?
|
Aorta | 3 | 2021 | 288 | 0.250 |
Why?
|
Software | 3 | 2022 | 665 | 0.240 |
Why?
|
Breast Neoplasms | 2 | 2016 | 3011 | 0.240 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 598 | 0.230 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2024 | 27 | 0.230 |
Why?
|
Italy | 3 | 2019 | 108 | 0.230 |
Why?
|
Amyloid | 1 | 2024 | 94 | 0.230 |
Why?
|
Cohort Studies | 5 | 2018 | 2872 | 0.220 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2024 | 178 | 0.220 |
Why?
|
Cardiomegaly, Exercise-Induced | 1 | 2022 | 1 | 0.220 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2023 | 312 | 0.220 |
Why?
|
Multimodal Imaging | 3 | 2023 | 111 | 0.210 |
Why?
|
Europe | 3 | 2021 | 321 | 0.210 |
Why?
|
Peptide Fragments | 1 | 2024 | 463 | 0.200 |
Why?
|
Electric Countershock | 1 | 2022 | 54 | 0.200 |
Why?
|
Follow-Up Studies | 8 | 2021 | 3666 | 0.190 |
Why?
|
Organ Size | 3 | 2019 | 371 | 0.190 |
Why?
|
Endocarditis | 1 | 2021 | 22 | 0.190 |
Why?
|
Treatment Outcome | 6 | 2022 | 8241 | 0.190 |
Why?
|
Stress, Mechanical | 3 | 2016 | 253 | 0.190 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2022 | 71 | 0.190 |
Why?
|
Comorbidity | 3 | 2021 | 949 | 0.190 |
Why?
|
Heart Valve Prosthesis | 1 | 2021 | 98 | 0.180 |
Why?
|
Survival Analysis | 4 | 2018 | 1534 | 0.180 |
Why?
|
Virtual Reality | 1 | 2020 | 24 | 0.180 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 1047 | 0.170 |
Why?
|
Pulmonary Artery | 2 | 2019 | 319 | 0.170 |
Why?
|
Aminobutyrates | 1 | 2019 | 13 | 0.170 |
Why?
|
Tetrazoles | 1 | 2019 | 24 | 0.170 |
Why?
|
Vascular Stiffness | 1 | 2019 | 29 | 0.170 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 46 | 0.170 |
Why?
|
Vasodilation | 1 | 2019 | 93 | 0.170 |
Why?
|
Protease Inhibitors | 1 | 2019 | 73 | 0.170 |
Why?
|
Chicago | 3 | 2019 | 1427 | 0.170 |
Why?
|
Time Factors | 6 | 2019 | 5338 | 0.170 |
Why?
|
Gadolinium | 2 | 2023 | 103 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 6 | 2020 | 2661 | 0.160 |
Why?
|
Septal Occluder Device | 1 | 2019 | 45 | 0.160 |
Why?
|
Case-Control Studies | 3 | 2024 | 1862 | 0.160 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2019 | 69 | 0.160 |
Why?
|
Diuretics | 1 | 2019 | 75 | 0.160 |
Why?
|
Forecasting | 2 | 2018 | 306 | 0.160 |
Why?
|
Cicatrix | 1 | 2019 | 68 | 0.160 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 1714 | 0.150 |
Why?
|
Quebec | 2 | 2015 | 11 | 0.150 |
Why?
|
Dilatation | 1 | 2018 | 48 | 0.150 |
Why?
|
Ultrasonography | 1 | 2020 | 712 | 0.150 |
Why?
|
Tachycardia, Ventricular | 1 | 2019 | 124 | 0.150 |
Why?
|
Reference Standards | 1 | 2018 | 144 | 0.150 |
Why?
|
Feasibility Studies | 5 | 2019 | 780 | 0.150 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 306 | 0.150 |
Why?
|
Device Removal | 1 | 2019 | 168 | 0.150 |
Why?
|
Body Size | 1 | 2017 | 92 | 0.140 |
Why?
|
ROC Curve | 4 | 2024 | 781 | 0.140 |
Why?
|
Coronary Stenosis | 1 | 2016 | 39 | 0.140 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2017 | 52 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 711 | 0.140 |
Why?
|
Carcinoembryonic Antigen | 1 | 1996 | 40 | 0.130 |
Why?
|
Adolescent | 7 | 2022 | 9263 | 0.130 |
Why?
|
Radiation Protection | 1 | 2016 | 26 | 0.130 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2015 | 33 | 0.130 |
Why?
|
Societies, Medical | 1 | 2019 | 575 | 0.130 |
Why?
|
Phenotype | 1 | 2022 | 2440 | 0.130 |
Why?
|
Artificial Intelligence | 3 | 2024 | 322 | 0.130 |
Why?
|
Radionuclide Imaging | 1 | 2016 | 221 | 0.130 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2015 | 67 | 0.120 |
Why?
|
Coronary Vessels | 1 | 2016 | 190 | 0.120 |
Why?
|
Chordae Tendineae | 1 | 2015 | 23 | 0.120 |
Why?
|
Emergency Medical Services | 1 | 2018 | 238 | 0.120 |
Why?
|
Biomechanical Phenomena | 1 | 2016 | 476 | 0.120 |
Why?
|
Flow Cytometry | 1 | 1996 | 691 | 0.120 |
Why?
|
Familial Primary Pulmonary Hypertension | 1 | 2013 | 60 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 266 | 0.110 |
Why?
|
Heart Block | 1 | 2013 | 31 | 0.110 |
Why?
|
Cost Savings | 1 | 2013 | 69 | 0.110 |
Why?
|
Models, Economic | 1 | 2013 | 62 | 0.110 |
Why?
|
Color | 1 | 2013 | 85 | 0.110 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 70 | 0.110 |
Why?
|
Disease Management | 1 | 2015 | 329 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 199 | 0.100 |
Why?
|
Tertiary Care Centers | 1 | 2012 | 106 | 0.100 |
Why?
|
Workflow | 2 | 2023 | 80 | 0.100 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 784 | 0.100 |
Why?
|
Population Surveillance | 1 | 2012 | 216 | 0.090 |
Why?
|
Clinical Competence | 1 | 2017 | 784 | 0.090 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 461 | 0.090 |
Why?
|
Antibodies, Monoclonal | 1 | 1996 | 1412 | 0.080 |
Why?
|
Computer Simulation | 1 | 2013 | 1097 | 0.080 |
Why?
|
Prevalence | 2 | 2024 | 1243 | 0.080 |
Why?
|
Surveys and Questionnaires | 1 | 2016 | 2624 | 0.070 |
Why?
|
Risk Assessment | 4 | 2017 | 2303 | 0.070 |
Why?
|
United States | 4 | 2024 | 6989 | 0.070 |
Why?
|
Elastic Modulus | 2 | 2016 | 36 | 0.070 |
Why?
|
Electrocardiography | 2 | 2021 | 494 | 0.070 |
Why?
|
Cause of Death | 2 | 2017 | 269 | 0.060 |
Why?
|
Education, Medical, Continuing | 2 | 2016 | 105 | 0.060 |
Why?
|
Cardiology | 2 | 2016 | 115 | 0.060 |
Why?
|
Healthy Aging | 1 | 2024 | 11 | 0.060 |
Why?
|
Walk Test | 1 | 2024 | 24 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 51 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2016 | 899 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 155 | 0.060 |
Why?
|
Prealbumin | 1 | 2023 | 34 | 0.060 |
Why?
|
Radiology | 2 | 2016 | 201 | 0.050 |
Why?
|
Brazil | 1 | 2023 | 74 | 0.050 |
Why?
|
Ultrasonography, Doppler | 1 | 2023 | 85 | 0.050 |
Why?
|
Athletes | 1 | 2022 | 52 | 0.050 |
Why?
|
Disease Progression | 2 | 2016 | 1489 | 0.050 |
Why?
|
Cardiac Output | 1 | 2021 | 156 | 0.050 |
Why?
|
Abscess | 1 | 2021 | 94 | 0.050 |
Why?
|
Random Allocation | 1 | 2020 | 327 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2020 | 200 | 0.040 |
Why?
|
Valsartan | 1 | 2019 | 11 | 0.040 |
Why?
|
Neprilysin | 1 | 2019 | 41 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2019 | 55 | 0.040 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 59 | 0.040 |
Why?
|
Arterial Pressure | 1 | 2019 | 38 | 0.040 |
Why?
|
Drug Combinations | 1 | 2019 | 203 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2019 | 123 | 0.040 |
Why?
|
Aging | 1 | 2024 | 718 | 0.040 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2019 | 113 | 0.040 |
Why?
|
Hospitals | 1 | 2021 | 299 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2021 | 387 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 71 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 337 | 0.040 |
Why?
|
Cost of Illness | 1 | 2018 | 147 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 281 | 0.040 |
Why?
|
Prosthesis Fitting | 1 | 2017 | 16 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2021 | 1072 | 0.040 |
Why?
|
Hypertonic Solutions | 1 | 1996 | 17 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 337 | 0.030 |
Why?
|
Culture Media | 1 | 1996 | 147 | 0.030 |
Why?
|
Databases, Factual | 1 | 2019 | 856 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2016 | 121 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2016 | 242 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2015 | 270 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2016 | 226 | 0.030 |
Why?
|
Exercise Test | 1 | 2015 | 165 | 0.030 |
Why?
|
Animals | 1 | 2014 | 27371 | 0.030 |
Why?
|
Automation | 1 | 2015 | 111 | 0.030 |
Why?
|
Stomach | 1 | 2015 | 111 | 0.030 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2014 | 19 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2014 | 27 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 1057 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 274 | 0.030 |
Why?
|
Pilot Projects | 1 | 2016 | 871 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 860 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 851 | 0.030 |
Why?
|
Life Expectancy | 1 | 2012 | 89 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2012 | 225 | 0.030 |
Why?
|
Biopsy | 1 | 2016 | 1184 | 0.020 |
Why?
|
Incidence | 1 | 2016 | 1595 | 0.020 |
Why?
|
Registries | 1 | 2016 | 784 | 0.020 |
Why?
|
Robotic Surgical Procedures | 1 | 2015 | 306 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2012 | 717 | 0.020 |
Why?
|
Stroke | 1 | 2014 | 986 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 2415 | 0.010 |
Why?
|